Great to see Oncosil ( currently $14 million market cap approx ) making noise getting the story out there , increasing awareness , widening its potential. Strong team including some from Sirtex , TLX Telix Pharmaceutical Limited , around a $4.5 billion market cap. I was a investor with Sirtex for a while and I remember well the set backs when trading around $40 being sold down to around $10 but the stock price and company made a very impressive turnaround and was taken over.
OSL have a treatment which is being introduced into new markets , well funded and do seem more eager to update investors which could lead to a change in sentiment. Sales definitely could be better but it seems a major focus could be on creating as much interest as possible through selling the story , further approvals, educating , trials , more data before a potential take over bid.
Sheesh the market cap under 20 Million with an actual device they are marketing, in trials and selling compared to some asx listed Biotechs in pre clinical or phase 1 studies with a similar or a higher market cap. Current market cap vs potential really does seem to great value but as they say always do your own research as this sector can be brutal. Interesting times ahead.
